Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2005
04/07/2005WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
04/07/2005WO2005030151A2 Compounds and compositions as protein kinase inhibitors
04/07/2005WO2005030150A2 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF
04/07/2005WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
04/07/2005WO2005009975A3 Benzimidazole derivatives as mek inhibitors
04/07/2005WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/07/2005WO2005000249A3 Preparation of chemical compounds
04/07/2005WO2004113286A3 Mucin synthesis inhibitors
04/07/2005WO2004112719A3 Chemical compounds
04/07/2005WO2004091488A3 Estrogen receptor modulators
04/07/2005WO2004048922A3 Bead-based detection of ligand-gpcr-g protein complexes
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient
04/07/2005US20050075507 1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
04/07/2005US20050075390 HIV protease inhibitors
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075366 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
04/07/2005US20050075357 5-arylpyrimidines as anticancer agents
04/07/2005US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS
04/07/2005US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/07/2005US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage
04/07/2005US20050075344 Melanocortin receptor agonists
04/07/2005US20050075334 Novel compounds
04/07/2005US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050075330 Dipeptidyl peptidase inhibitors
04/07/2005US20050075269 Substituted benzofuran-2-carboxamides derivatives
04/07/2005US20050074748 Bioreactive agents
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/07/2005CA2540518A1 Compounds and compositions as protein kinase inhibitors
04/07/2005CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
04/07/2005CA2540019A1 Quinazoline derivatives as antiproliferative agents
04/07/2005CA2540008A1 Quinazoline derivatives
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/07/2005CA2539731A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
04/07/2005CA2539471A1 Carbamoyl-type benzofuran derivatives
04/07/2005CA2539250A1 Biphenyloxy-acids
04/07/2005CA2539235A1 5-arylpyrimidines as anticancer agents
04/07/2005CA2538711A1 Substituted heteroaryl benzofuran acids
04/06/2005EP1520856A1 Androgen receptor agonist
04/06/2005EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone
04/06/2005EP1520472A2 Herbicidal compositions comprising pyridoyl-1,3-cyclodiones
04/06/2005EP1520450A1 Electroluminescent device
04/06/2005EP1519921A2 Substituted anthranilic amide derivatives and methods of use
04/06/2005EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors
04/06/2005EP1519919A1 Indolin phenylsulfonamide derivatives
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1412351A4 Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom
04/06/2005EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
04/06/2005EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
04/06/2005EP1218357B1 Quinazoline derivatives
04/06/2005EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives
04/06/2005CN1604893A Cyclic amine compounds
04/06/2005CN1604778A Cis-imidazolines
04/06/2005CN1604777A Method of treatment
04/06/2005CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
04/06/2005CN1195770C Preparation of d4T from 5-methyl uridine
04/06/2005CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses
04/06/2005CN1195740C Pharmaceutical compositions comprising 2-quinolones
04/06/2005CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
04/06/2005CN1195526C Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside
04/06/2005CN1195522C Benzodiazepine derivatives
04/05/2005US6875875 Process for preparing glycidylphthalimide
04/05/2005US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
04/05/2005US6875859 Heterocyclic compounds and their use in the detection of nucleic acids
04/05/2005US6875791 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
04/05/2005US6875789 Pyrazole-derived kinase inhibitors and uses thereof
04/05/2005US6875780 Compounds that modulate PPAR activity and methods for their preparation
04/05/2005US6875779 Cyclooxygenase inhibitor
04/05/2005US6875777 Compounds
04/05/2005US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases
04/05/2005US6875770 Antiinflamamtory agents; side effect reduction
04/05/2005US6875769 Substituted6,6-hetero-bicyclicderivatives
04/05/2005US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
04/05/2005US6875764 Urea and thiourea compounds useful for treatment of coccidiosis
04/05/2005US6875761 Certain 1,3-disubstituted isoquinoline derivatives
04/05/2005CA2270086C New benzothiophene, benzofuranic and indolic derivatives, their preparation process and pharmaceutical compositions containing them
04/05/2005CA2245686C In situ block copolymer formation during polymerization of a vinyl aromatic monomer
03/2005
03/31/2005WO2005028465A1 Chromene compound
03/31/2005WO2005028448A1 Benzyl-benzimidazolyl derivatives
03/31/2005WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005WO2005028443A2 Protein tyrosine kinase enzyme inhibitors
03/31/2005WO2005028440A1 Novel gamma secretase inhibitors
03/31/2005WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
03/31/2005WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
03/31/2005WO2004108133A3 Modulators of vr1 receptor
03/31/2005WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/31/2005WO2003073987A3 Compounds that modulate the activity of ptp-1b and tc-ptp
03/31/2005US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
03/31/2005US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease
03/31/2005US20050070712 Pyrimidine derivatives as ghrelin receptor modulators
03/31/2005US20050070709 dealkylation of a benzodioxane aniline in presence of chloroethanol
03/31/2005US20050070706 Antidiabetic agents; obesity; controlling appetite
03/31/2005US20050070605 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin
03/31/2005US20050070598 Using 4-oxot perhydro( furan or pyran)-3-yl carbamoyl derivative; bone disorders; oral disease; antiarthritic agents
03/31/2005US20050070589 Pyrazolyl inhibitors of 15- lipoxygenase
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 694